Principles of Cancer Biotherapy

  • Robert K. Oldham
  • Robert O. Dillman

Table of contents

  1. Front Matter
    Pages i-xi
  2. Robert K. Oldham
    Pages 1-16
  3. Sun-Jin Kim, Cheryl Hunt Baker, Yasuhiko Kitadai, Toru Nakamura, Toshio Kuwai, Takamitsu Sasaki et al.
    Pages 17-40
  4. Kapil Mehta, Bulent Ozpolat, Kishorchandra Gohil, Bharat B. Aggarwal
    Pages 53-83
  5. Robert K. Oldham
    Pages 85-99
  6. Kenneth A. Foon, Malek M. Safa
    Pages 147-153
  7. Walter M. Lewko, Robert K. Oldham
    Pages 155-276
  8. David Goldstein, Robert Jones, Richard V. Smalley, Ernest C. Borden
    Pages 277-301
  9. Robert O. Dillman
    Pages 303-406
  10. Arthur E. Frankel, Jung-Hee Woo, David M. Neville
    Pages 407-449
  11. Malek Safa, Kenneth A. Foon, Robert K. Oldham
    Pages 451-462
  12. John M. Pagel, Otto C. Boerman, Hazel B. Breitz, Ruby F. Meredith
    Pages 463-496
  13. Kapil Mehta, Robert K. Oldham, Bulent Ozpolat
    Pages 527-568
  14. MaryAnn Foote, George Morstyn
    Pages 569-580
  15. Maryann Foote, George Morstyn
    Pages 581-588
  16. Donald J. Buchsbaum, C. Ryan Miller, Lacey R. Mcnally, Sergey A. Kaliberov
    Pages 589-612
  17. Robert K. Oldham, Robert O. Dillman
    Pages 631-632
  18. Robert K. Oldham
    Pages 633-644
  19. Robert K. Oldham
    Pages 645-658
  20. Robert O. Dillman
    Pages 659-668
  21. Robert O. Dillman
    Pages 669-678
  22. Robert O. Dillman
    Pages 679-691
  23. Robert K. Oldham
    Pages 711-712
  24. Robert O. Dillman
    Pages 723-732
  25. Robert K. Oldham
    Pages 733-738
  26. Back Matter
    Pages 739-742

About this book


At the time of the first edition of Principles of Cancer Biotherapy in 1987, this book represented the first comprehensive textbook on biological therapy. In 1991, when the second edition was published, there was still some doubt on the part of many oncologists and cancer researchers as to the therapeutic value of these new approaches. By 2003 and the fourth edition, it was generally agreed that biopharmaceuticals were producing major opportunities for new cancer therapies. Cancer biotherapy has now truly matured into the fourth modality of cancer treatment. This fifth revised edition describes the tremendous progress that has been made in recent years using biologicals in cancer treatment.

This book summarizes an evolving science and a rapidly changing medical practice in biotherapy. In this new millennium, it is now possible to envision a much more diversified system of cancer research and treatment that will afford greater opportunities for a patient’s personalized cancer treatment. This was first envisioned in the 1987 initial edition of this textbook and is now a "new" and popular approach to cancer treatment. Some forms of cancer biotherapy use the strategy of tumor stabilization and control though continued biological therapy, akin to the use of insulin in the treatment of diabetes.

This textbook illustrates new methods of thinking and new strategies for control of cancer. It is always difficult to move from past dogma to future opportunity, but this fifth edition of Principles of Cancer Biotherapy illustrates why it is so important to the patients for researchers and clinicians to explore and quickly apply these new opportunities in cancer biotherapy.


Tumor gene therapy interferon therapy transplantation

Editors and affiliations

  • Robert K. Oldham
    • 1
  • Robert O. Dillman
    • 2
    • 3
  1. 1.Hematology-Oncology Associates of Southeast Missouri Hospital, Southeast Medical PlazaCape GirardeauUSA
  2. 2.Hoag Cancer CenterNewport BeachUSA
  3. 3.University of CaliforniaIrvineUSA

Bibliographic information